# Eplerenone for the Treatment of Central Serous Chorioretinopathy

> **NCT01990677** · NA · COMPLETED · sponsor: **Wills Eye** · enrollment: 108 (actual)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DRUG:** 25mg Eplerenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01990677
- **Lead sponsor:** Wills Eye
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-05
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2018-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990677, "Eplerenone for the Treatment of Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01990677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*